Some of our researchers are engaged in research that provides a basic understanding of how vision works. This provides the raw material used by other researchers to develop an understanding of what step is compromised when the eye is diseased or injured.

Other researchers use this visual process information in normal and diseased eyes to design and test therapies that address visual process defects associated with disease or trauma. For example, some of our biochemists, cell biologists, and bioengineers study the basic cellular and molecular composition and morphology (shape, thickness, etc.) of normal ocular tissue using cutting-edge tissue culture and imaging technology.

Still other researchers study how these characteristics change in diseases or situations like:

  • keratoconus
  • glaucoma
  • age-related macular degeneration
  • during infections with viruses, bacteria, and fungi
  • following wounding after trauma or ocular surgery

Different researchers use this knowledge to develop new treatments designed to correct defects in the visual process resulting from disease and trauma. They develop innovative solutions like:

  • novel drugs or drug delivery systems
  • new vaccination approaches
  • laser-based treatments
  • cameras that bypass the eye and send visual information to the brain
  • bioengineering of ocular tissue